Abstract
The hereditary disorder acute intermittent porphyria is potentially fatal. Many more females present with active disease than males and some have attacks related to their menstrual cycle and pregnancy. We present a female patient who was diagnosed while pregnant at 19 years. She subsequently developed life-threatening attacks pre-menstrually at 24 years; these were associated with weight loss. Initial treatment was with high calorie feeding via a naso-gastric tube, followed by a gastrostomy. Subsequent gonadotrophin suppression with intranasal luteinizing hormone-releasing hormone analogue (buserelin) thrice daily met with limited success. We implanted 100 mg of testosterone subcutaneously in November 1989. The buserelin was discontinued in January 1990 and menses returned 3 months later. There have been no serious attacks since then. Repeat implantation was performed at 6 monthly intervals until her present pregnancy. Baseline biochemical parameters have remained high and unaltered despite treatment although the testosterone has clearly had a marked clinical benefit, without side effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson K. E., Bradlow H. L., Sassa S., Kappas A. Studies in porphyria. VIII. Relationship of the 5 alpha-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria. Am J Med. 1979 Apr;66(4):644–650. doi: 10.1016/0002-9343(79)91176-8. [DOI] [PubMed] [Google Scholar]
- Granick S., Kappas A. Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation. J Biol Chem. 1967 Oct 25;242(20):4587–4593. [PubMed] [Google Scholar]
- McColl K. E., Wallace A. M., Moore M. R., Thompson G. G., Goldberg A. Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) 1982 Feb;62(2):183–191. doi: 10.1042/cs0620183. [DOI] [PubMed] [Google Scholar]
- Straka J. G., Rank J. M., Bloomer J. R. Porphyria and porphyrin metabolism. Annu Rev Med. 1990;41:457–469. doi: 10.1146/annurev.me.41.020190.002325. [DOI] [PubMed] [Google Scholar]
- Takayasu S., Adachi K. The in vivo and in vitro conversion of testosterone to 17 -hydroxy-5 -adrosten-3-one (dihydrotestosterone) by the sebaceous gland of hamsters. Endocrinology. 1972 Jan;90(1):73–80. doi: 10.1210/endo-90-1-73. [DOI] [PubMed] [Google Scholar]